https://www.selleckchem.com/pr....oducts/pifithrin-u.h
This group was also more likely to understand that repeat treatments are necessary than those undergoing one treatment. No research to date has systematically explored patient-reported factors that promote retreatment of onabotulinumtoxinA for overactive bladder. This novel, mixed-methods approach indicates that patient comfort and patient knowledge were the strongest predictors of previous retreatment and anticipated retreatment, suggesting concrete avenues for improved periprocedural patient counselling and education. No research
Aimer
Commentaire
Partagez
